Myomar Molecular Eyes Patent, Crowdfunding

Halifax biomarker-testing startup Myomar Molecular is ramping up clinical trials and preparing to file a patent application, as it eyes a possible crowdfunding campaign to raise capital later this year.
Myomar, which is developing a urine test to monitor muscle degeneration, was founded in 2021 by Dalhousie University biochemist and molecular biology PhD Rafaela Andrade. The company just raised